Recombinant immunotoxins (RITs) are fusions of an Fv-based targeting moiety and a toxin. Pseudomonas exotoxin A (PE) has been used to make several immunotoxins that have been evaluated in clinical trials. Immunogenicity of the bacterial toxin and off-target toxicity have limited the efficacy of these immunotoxins. To address these issues, we have previously made RITs in which the Fv is connected to domain III (PE24) by a furin cleavage site (FCS), thereby removing unneeded sequences of domain II. However, the PE24 containing RITs do not contain the naturally occurring disulfide bond around the furin cleavage sequence, because it was removed when domain II was deleted. This could potentially allow PE24 containing immunotoxins to be cleaved and inactivated before internalization by cell surface furin or other proteases in the blood stream or tumor microenvironment. Here, we describe five new RITs in which a disulfide bond is engineered to protect the FCS. The most active of these, SS1-Fab-DS3-PE24, shows a longer serum half-life than an RIT without the disulfide bond and has the same anti-tumor activity, despite being less cytotoxic in vitro. These results have significance for the production of de-immunized, low toxicity, PE24-based immunotoxins with a longer serum half-life.
http://ift.tt/2aqUhSu
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
▼
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
-
▼
Ιουλίου
(489)
-
▼
Ιουλ 24
(24)
- Statins, familial hypercholesterolemia, and type 2...
- Response to Dr. Gerald M Reaven: good news for pat...
- Sensors, Vol. 16, Pages 1163: A Sensor Array for t...
- Sustainability, Vol. 8, Pages 699: Sustainable Cul...
- Sustainability, Vol. 8, Pages 707: New Product Dev...
- Toxins, Vol. 8, Pages 217: Protection of the Furin...
- Forests, Vol. 7, Pages 152: Timber Regulation and ...
- Cosmetics, Vol. 3, Pages 27: Overview of Skin Whit...
- Energies, Vol. 9, Pages 578: A Review of Dangerous...
- Gene activation by metazoan enhancers: Diverse mec...
- Cosmetics, Vol. 3, Pages 26: Human Hair and the Im...
- Sensors, Vol. 16, Pages 1157: Real Time 3D Facial ...
- Energies, Vol. 9, Pages 574: Artificial Neural Net...
- Diseases, Vol. 4, Pages 26: Human Coronaviruses: A...
- Beverages, Vol. 2, Pages 18: Phenolic Composition ...
- Axial length, refraction, and retinal vascularizat...
- Clinical & Pathological Studies of Upper Gastroint...
- Mitochondria and oxidative stress in heart aging
- Plant responses to tomato chlorotic mottle virus: ...
- Proteomic identification of putative biomarkers fo...
- Laboratory Simulation of an Iron(II)-rich Precambr...
- Intracerebroventricular and Intravascular Injectio...
- Phenotypic characterization of a pair of molecules...
- Watershed Planning within a Quantitative Scenario ...
-
▼
Ιουλ 24
(24)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Κυριακή 24 Ιουλίου 2016
Toxins, Vol. 8, Pages 217: Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
https://ift.tt/2MQ8Ai8
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.